Summary
Studies were performed on the activation of human blood monocytes to the antitumor state by a dried preparation of multilamellar vesicle (MLV) liposomes in which synthetic muramyl tripeptide phosphatidylethanolamine (MTP-PE) was inserted directly into the liposome membrane. Dried liposomes composed of synthetic phospholipids [phosphatidylcholine (PC) and phosphatidylserine (PS) in a molar ratio of 7:3] were prepared by lyophilization. Dried liposome-MTP-PE was found to be superior in several ways to free desmethyl muramyl dipeptide (norMDP) or conventional liposome-MTP-PE, prepared immediately before use. First, dried lipsome-MTP-PE was stable and strongly activated monocytes when stored for over 3 months in a freezer at −°C or even in suspension at 4°C. Second, human monocytes in suspension, as well as in the adherent form, were activated to the tumoricidal state by interaction for at least 4 h with the dried preparation of liposome-MTP-PE. Third, monocytes activated with the dried liposome-MTP-PE or conventionally prepared liposome-MTP-PE maintained their tumoricidal activity for a longer period (4 days) than those activated with free norMDP. These results indicate that the dried preparation of liposome-MTP-PE can be stored for a long time, has a reproducible effect that can be standardized and should be valuable for in situ activation of human monocytes to the tumoricidal state, which is associated with eradication of cancer metastases.
Similar content being viewed by others
References
Deodhar SD, James K, Chiang T, Edinger M, Barna BP (1982) Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein. Cancer Res 42:5084
Fidler IJ, Raz A, Fogler WE, Kirsh R, Bugelski P, Poste G (1980) The design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res 140:4460
Fidler IJ, Raz A, Fogler WE, Hoyer LC, Poste G (1981) The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes. Cancer Res 41:495
Fidler IJ, Sone S, Fogler WE, Barnes ZL (1981) Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci USA 78:1680
Fidler IJ, Sone S, Fogler WE, Smith D, Braun DG, Tarcsay V, Gisler RH, Schroit AJ (1982) Efficacy of liposomes containing a lipophilic muramyl dipeptide derivative for activating the tumoricidal properties of alveolar macrophages in vivo. J Biol Response Mod 1:43
Fidler IJ, Barnes ZL, Fogler WE, Kirsh R, Bugelski P, Poste G (1982) Involvement of macrophages in the eradication of established metastases following intravenous injection of established metastases following intravenous injection of macrophage activators. Cancer Res 42:496
Hibbs JB Jr (1976) Role of activated macrophages in nonspecific resistance to neoplasia. J Reticuloendothel Soc 20:233
Key ME, Talmadge JE, Fogler WE, Bucana C, Fidler IJ (1982) Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide. J Natl Cancer Inst 69:1189
Kleinerman ES, Erickson KI, Schroit A, Fogler WE, Fidler IJ (1983) Activation of tumoricidal properties in human blood monocytes by liposomes containing muramyl tripeptide Cancer Res 43:2010
Kleinerman ES, Schroit AJ, Fogler WE, Fidler IJ (1983) Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines. J Clin Ivest 72:304
Lopez-Berestein G, Mehta K, Mehta R, Juliano RL, Hersh ER (1983) The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues. J Immunol 130:1500
Phillips NV, Moras ML, Chedid L, Lefrancier P, Bernard JM (1985) Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative. Cancer Res 45:128
Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283:139
Poste G, Kirsh R, Fogler WE, Fidler IJ (1979) Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. Cancer Res 39:881
Saiki I, Fidler IJ (1985) Synergism between muramyl dipeptide and gamma interferon for activation of mouse alveolar macrophages. J Immunol 135:2022
Saiki S, Sone S, Fogler WE, Kleinerman ES, Lopez-Berestein G, Fidler IJ (1985) Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes. Cancer Res 45:6188
Schroit AJ, Fidler IJ (1982) Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res 42:161
Sone S, Fidler IJ (1980) Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages. J Immunol 125:2454
Sone S, Fidler IJ (1981) In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes. Cell Immunol 57:42
Sone S, Fidler IJ (1981) Activation of rat alveolar macrophages to the tumoricidal state in the presence of progressively growing pulmonary metastases. Cancer Res 42:2401
Sone S, Tsubura E (1982) Human alveolar macrophages: Potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide. J Immunol 129:1313
Sone S, Poste G, Fidler IJ (1980) Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines. J Immunol 24:2197
Sone S, Mutsuura S, Ogawara M, Tsubura E (1983) Stimulatory effect of lipophilic muramyl dipeptide analog encapsulated in liposomes on the tumoricidal activity of human peripheral blood monocytes. In: Manipulation of host defense mechanisms. Excerpta Medica, Tokyo, p 28
Sone S, Tachibana K, Shono M, Ogushi F, Tsubura E (1983) Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages. J Biol Response Mod 3:185
Sone S, Mutsuura S, Ogawara M, Tsubura E (1984) Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes. J Immunol 132:2105
Sone S, Mutsuura S, Ogawara M, Utsugi T, Tsubura E (1984) Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state. Cancer Immunol Immunother 18:169
Sone S, Lopez-Berestein G, Fidler IJ (1985) Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state. J Natl Cancer Inst 74:583
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sone, S., Utsugi, T., Tandon, P. et al. A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor state. Cancer Immunol Immunother 22, 191–196 (1986). https://doi.org/10.1007/BF00200032
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00200032